Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder
暂无分享,去创建一个
S. Scherer | M. Uddin | K. Tammimies | Dongmei Zhao | Z. Gai | Yi Liu | Xiaomeng Yang | Rui Dong | Yanqing Zhang
[1] Colleen M Niswender,et al. Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications. , 2014, Cellular signalling.
[2] Pinchen Yang,et al. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets. , 2014, Current pharmaceutical design.
[3] Thomas Bourgeron,et al. The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism , 2014, Nature Communications.
[4] Daniele Merico,et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder , 2014, Nature Genetics.
[5] Bung-Nyun Kim,et al. The metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorder. , 2014, Journal of child and adolescent psychopharmacology.
[6] H. Gurling,et al. Allelic Association, DNA Resequencing and Copy Number Variation at the Metabotropic Glutamate Receptor GRM7 Gene Locus in Bipolar Disorder , 2014, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[7] Stephen J. Guter,et al. Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.
[8] M. Fendt,et al. Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior♦ , 2014, The Journal of Biological Chemistry.
[9] À. Bayés,et al. Glutamate receptor mutations in psychiatric and neurodevelopmental disorders , 2014, Communicative & integrative biology.
[10] Lars Feuk,et al. The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..
[11] Valsamma Eapen,et al. Exploring Links between Genotypes, Phenotypes, and Clinical Predictors of Response to Early Intensive Behavioral Intervention in Autism Spectrum Disorder , 2013, Front. Hum. Neurosci..
[12] D. Hoyer,et al. Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse , 2013, Neuropharmacology.
[13] M. Fendt,et al. Differential roles of mGlu7 and mGlu8 in amygdala-dependent behavior and physiology , 2013, Neuropharmacology.
[14] A. Serretti,et al. Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR⁎D , 2013, European Neuropsychopharmacology.
[15] S. Scherer,et al. Autism spectrum disorder in the genetics clinic: a review , 2013, Clinical genetics.
[16] D. Manahan‐Vaughan,et al. Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning , 2013, Neuropharmacology.
[17] You Yang,et al. Role of metabotropic glutamate receptor 7 in autism spectrum disorders: a pilot study. , 2013, Life sciences.
[18] Michael E. Greenberg,et al. Activity-dependent neuronal signalling and autism spectrum disorder , 2013, Nature.
[19] Jung-Woo Son,et al. Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample , 2013, Behavioral and Brain Functions.
[20] WeiQiang Liu,et al. [Analysis of de novo copy number variations in a family affected with autism spectrum disorders using high-resolution array-based comparative genomic hybridization]. , 2012, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[21] U. Rajamma,et al. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders , 2012, Pharmacology Biochemistry and Behavior.
[22] Zhen Yan,et al. Regulation of N-Methyl-d-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7*♦ , 2012, The Journal of Biological Chemistry.
[23] Susanne Walitza,et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder , 2011, Nature Genetics.
[24] Geraldine Dawson,et al. Risk factors for autism: translating genomic discoveries into diagnostics , 2011, Human Genetics.
[25] F. Nicoletti,et al. Metabotropic glutamate receptors: From the workbench to the bedside , 2011, Neuropharmacology.
[26] S. Purcell,et al. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample , 2011, European Journal of Human Genetics.
[27] J. Cryan,et al. Metabotropic glutamate receptor 7: at the interface of cognition and emotion. , 2010, European journal of pharmacology.
[28] P. Conn,et al. Metabotropic glutamate receptors: physiology, pharmacology, and disease. , 2010, Annual review of pharmacology and toxicology.
[29] C. Bennett,et al. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. , 2010, Annual review of pharmacology and toxicology.
[30] W. Maier,et al. A family-based association study of DNA sequence variants in GRM7 with schizophrenia in an Indonesian population. , 2009, The international journal of neuropsychopharmacology.
[31] J. Knowles,et al. Novel loci for major depression identified by genome-wide association study of STAR*D and meta-analysis of three studies , 2009, Molecular Psychiatry.
[32] V. Sheffield,et al. Novel copy number variants in children with autism and additional developmental anomalies , 2009, Journal of Neurodevelopmental Disorders.
[33] Y. Fukumaki,et al. Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia , 2009, Psychiatry Research.
[34] B. Neale,et al. Genome‐wide association study of response to methylphenidate in 187 children with attention‐deficit/hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[35] M. Fendt,et al. mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity , 2008, Molecular Psychiatry.
[36] A. Singleton,et al. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.
[37] M. Itokawa,et al. A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia , 2008, Schizophrenia Research.
[38] R. D'Hooge,et al. Concomitant Deficits in Working Memory and Fear Extinction Are Functionally Dissociated from Reduced Anxiety in Metabotropic Glutamate Receptor 7-Deficient Mice , 2006, The Journal of Neuroscience.
[39] P. Kelly,et al. Antidepressant and anxiolytic‐like effects in mice lacking the group III metabotropic glutamate receptor mGluR7 , 2003, The European journal of neuroscience.
[40] H. L. Schulz,et al. Characterization of three novel isoforms of the metabotrobic glutamate receptor 7 (GRM7) , 2002, Neuroscience Letters.
[41] S. Nakanishi,et al. Metabotropic Glutamate Receptor Subtype 7 Ablation Causes Deficit in Fear Response and Conditioned Taste Aversion , 1999, The Journal of Neuroscience.
[42] D. Schoepp,et al. Metabotropic glutamate receptors , 1994, Pharmacology Biochemistry and Behavior.
[43] Y. Shinoda,et al. Animal models of autism spectrum disorder (ASD): a synaptic-level approach to autistic-like behavior in mice. , 2013, Experimental animals.
[44] J. Potash,et al. Novel loci for major depression identified by genome-wide association study of STAR*D and meta-analysis of three studies , 2009, Molecular Psychiatry.